Circa Group AS
OSE:CIRCA
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.419
3.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CIRCA stock under the Base Case scenario is 0.894 NOK. Compared to the current market price of 0.638 NOK, Circa Group AS is Undervalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Circa Group AS
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CIRCA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Circa Group AS
Balance Sheet Decomposition
Circa Group AS
Current Assets | 8.7m |
Cash & Short-Term Investments | 6.1m |
Receivables | 2.5m |
Other Current Assets | 47k |
Non-Current Assets | 32.1m |
Long-Term Investments | 33k |
PP&E | 32m |
Intangibles | 19k |
Other Non-Current Assets | 1k |
Current Liabilities | 12.2m |
Accounts Payable | 8.9m |
Accrued Liabilities | 152k |
Other Current Liabilities | 3.1m |
Non-Current Liabilities | 68k |
Other Non-Current Liabilities | 68k |
Earnings Waterfall
Circa Group AS
Revenue
|
1.6m
EUR
|
Cost of Revenue
|
-401k
EUR
|
Gross Profit
|
1.2m
EUR
|
Operating Expenses
|
-7.9m
EUR
|
Operating Income
|
-6.7m
EUR
|
Other Expenses
|
370k
EUR
|
Net Income
|
-6.3m
EUR
|
Free Cash Flow Analysis
Circa Group AS
EUR | |
Free Cash Flow | EUR |
During the Q2 2024 earnings call, Circa Group announced a funding requirement of €60 million due to increased project costs and delays. The ReSolute project is pivotal, with expectations to secure necessary environmental permits by year-end 2024. The company plans to launch operations by late 2025, targeting high-value applications that align with market demand. They highlighted ongoing cost management measures, while leveraging strong support from French authorities in their funding endeavors. Future growth hinges on effective marketing strategies, with a focus on expanding distribution partnerships, particularly in pharmaceuticals and specialty chemicals.
What is Earnings Call?
CIRCA Profitability Score
Profitability Due Diligence
Circa Group AS's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
Score
Circa Group AS's profitability score is 24/100. The higher the profitability score, the more profitable the company is.
CIRCA Solvency Score
Solvency Due Diligence
Circa Group AS's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Circa Group AS's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CIRCA Price Targets Summary
Circa Group AS
Dividends
Current shareholder yield for CIRCA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Circa Group AS is a biotechnology company, which engages in the production and sales of biochemicals. The company is headquartered in Oslo, Oslo. The company went IPO on 2021-03-02. The firm converts biomass into advanced bio-based chemicals using its proprietary Furacell process. The product portfolio is under development, and includes flavorings, biopolymers and bio-solvents such as Cyrene, an alternative to traditional polar aprotic solvents, which is produced in one step from platform biomolecule levoglucosenone. Cyrene, derived from Levoglucosenone (LGO), is greener, safer and often performs better than traditional toxic solvents used in paints, coatings, battery and textile applications as well as many more industrial processes. Circa Group AS has several subsidiaries, including Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV and Circa Group Pty. Ltd.
Officers
The intrinsic value of one CIRCA stock under the Base Case scenario is 0.894 NOK.
Compared to the current market price of 0.638 NOK, Circa Group AS is Undervalued by 29%.